Log in | Join Free | china | japan | germany

1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-

Request For Quotation
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Suppliers list
Company Name: Standardpharm Co. Ltd.
Tel: 86-714-3992388
Email: overseasales1@yongstandards.com
Products Intro: Product Name:Paricalcitol Impurity 5
CAS:95716-67-9
Purity:0.99 Package:10mg;25mg;50mg;100mg
Company Name: CR Corporation Lomited
Tel:
Email: fred.wen@crcorporation.cn
Products Intro: Product Name:(1R,3aR,4S,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol
CAS:95716-67-9
Company Name: Hangzhou Huarong Pharm Co., Ltd.
Tel: 571-86758373 +8613588754946
Email: sales@huarongpharm.com
Products Intro: Product Name:(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol
CAS:95716-67-9
Purity:0.99 Package:10MG,50MG,100MG,1G
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525
Email: masar@topule.com
Products Intro: Product Name:(1R,3aR,4S,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol
CAS:95716-67-9
Purity:98% Package:100mg;1g;500g Remarks:Topule Company operates with integrity and has its own laboratory, which supports packaging and customization. Payment will be made after the product has passed third-party testing
Company Name: Shanghai Payne Pharmaceutical Technology Co.Ltd
Tel: 021-58123769 18678586262
Email: info@paynepharm.com
Products Intro: Product Name:Paricalcitol-3
CAS:95716-67-9
Purity:95+% HPLC Package:10mg;25mg;50mg;100mg
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Basic information
Product Name:1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-
Synonyms:1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-;(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol;(1R,3aR,4S,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol;Paricalcitol Impurity 5;(1R,3aR,4S,7aR)-1-((2R,5S,E)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol;Paricalcitol-3;Paricalcitol impurity 3/(1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-1H-inden-4-ol;<1R<1β(R*,E,S*),3aα,4β,7aβ>>-6-(Octahydro-4-hydroxy-7a-methyl-1H-inden-1-yl)-2,3-dimethyl-4-hepten-2-ol
CAS:95716-67-9
MF:C19H34O2
MW:294.47
EINECS:
Product Categories:
Mol File:95716-67-9.mol
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Structure
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Chemical Properties
Boiling point 402.8±18.0 °C(Predicted)
density 0.997±0.06 g/cm3(Predicted)
pka14.93±0.29(Predicted)
Safety Information
MSDS Information
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Usage And Synthesis
1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)- Preparation Products And Raw materials
Raw materials(2S)-2-((1R,3aR,7aR)-4-(tert-butyldiMethylsilyloxy)-7a-Methyloctahydro-1H-inden-1-yl)propanal
Tag:1H-Inden-4-ol, octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-, (1R,3aR,4S,7aR)-(95716-67-9) Related Product Information
2-((3R,5R)-3,5-bis(tert-butyldiMethylsilyloxy)cyclohexylidene)ethanol 2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol PL-A':(1R,3aR,7aR)-1-((2R,5R,E)-6-hydroxy-5,6-dimethy lhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one PL-AS':(1R,3aR,7aR)-1-((2R,5R,Z)-6-hydroxy-5,6-dimeth ylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one benzyl (4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl) carbamate 1-(5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine (3S,6R,E)-6-((1R,3aS,7aR,E)-4-(2-((3R,5R)-3,5-bis ((tert-butyldimethylsilyl)oxy)cyclohexylidene) ethylidene)-7a-methyloctahydro-1H-inden-1-yl)- 2,3-dimethylhept-4-en-2-ol (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy- 5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H- inden-4-ylidene)ethylidene)cyclohexane-1,3-diol tert-butyl(((1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl -6-((tetrahydro-2H-pyran-2-yl)oxy)hept-3-en-2-yl) -7a-methyloctahydro-1H-inden-4-yl)oxy)dimethylsilane (1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((trimethylsilyl)oxy)hept-3-en-2-yl)-7a- methyloctahydro-4H-inden-4-one (1R,3aR,7aR)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept -3-en-2-yl)-7a-methyloctahydro-4H-inden-4-one (1R,3aR,7aR)-1-((2R,5S,E)-6-hydroxy-5,6-diMethylhept-3-en-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one